Drug Product
Analytical & Bioanalytical Services
Company Overview
About
Opocrin SpA is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Infectious Disease
Quick Facts
HQ:Italy
Founded:1990
Employees:2,834
Capabilities & Services
Core Capabilities
- Small Molecule API
- Small Molecule Drug Product
- Oral Solid Dose
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Oral Solid Dose
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Pilot Scale
Clinical
Commercial Scale
Markets Served
Global
Manufacturing Facilities
2 sites worldwide
OPOCRIN SPA
VIA ANTONIO PACINOTTI 3, FORMIGINE, 41043
Site Capabilities
2 capabilitiesANALYSIS
API MANUFACTURE
OPOCRIN SPA
VIA GAZZATE, 48, NONANTOLA, 41015
Site Capabilities
1 capabilityAPI MANUFACTURE
International Regulatory
EU GMP Certificates
20
Regulatory Bodies
EMA/EudraGMDP
Regulatory Approvals
Drug Approval ISI66E
Health Canada · #APR-1KHS8I4F · 2020-03-01
Drug Approval XWNISS
PMDA · #APR-NFWFXTOR · 2019-03-01
Certifications
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-MR20ZJTO
Issued: 2020-01-23
Expires: 2025-05-14
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-7RX5UAWV
Issued: 2020-05-27
Expires: 2025-04-18
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-VQSEWLJ2
Issued: 2020-08-05
Expires: 2025-07-04
WHO GMP
World Health Organization
Cert #: CERT-1L1O505G
Issued: 2020-02-02
Expires: 2025-07-17
Loading CDMO intelligence...
Key facts about Opocrin SpA
- Opocrin SpA is headquartered in Italy.
- Opocrin SpA was founded in 1990.
- Opocrin SpA has 2,834 employees.
- Opocrin SpA has 2 manufacturing sites listed on CDMO Hub, in FORMIGINE, Italy and NONANTOLA, Italy.
- Opocrin SpA's capabilities include Small Molecule API, Small Molecule Drug Product and Oral Solid Dose.
Find CDMOs like Opocrin SpA
Directory pages this company appears in, each with the full list of matching manufacturers.